Center for Cerebrovascular Research
UCSF
Hua Su

Hua Su, MD

Assistant Professor

San Francisco General Hospital
Center for Cerebrovascular Research
1001 Potrero Avenue, Box-1371
Building 10, 2nd Floor, Room 1206
San Francisco, CA 94110
phone: 415-206-3162
fax: 415-206-8907
email: suh@anesthesia.ucsf.edu


Education and Training

  • MD, Medicine, 1982, Nanjing Medical University, Nanjing, China
  • MS, Histology and Embryology, 1985, Xian Medical University, Xian, China
  • Postdoctoral Fellow, Reproductive Physiology, 1986, Beijing Medical University, Beijing, China
  • Postdoctoral Fellow, Medical Genetics, 1992, University of California, San Francisco, CA

Research Interests

  • Viral vector mediated targeted gene expression
  • Gene and cell based therapies for ischemic heart disease
  • Gene and cell based therapies for cerebral vascular diseases
  • Development of rodent arteriovenous malformation model

Selected Publications

  • H Kim, DA Marchuk, Y Chen, H Su, GY Yang, WL Young. Genetic considerations relevant to intracranial hemorrhage and brain arteriovenous malformations. Acta Neurochir, 2008 in press

  • *H Su, J Takagawa, Y Huang, J Arakawa-Hoyt, J Pons, W Grossman and YW Kan. Additive Effect of AAV Mediated Angiopoietin-1 and VEGF Expression on the Therapy of Infarcted Heart. Int J Cardio. Online published 2008 (Feb). (*corresponding author)

  • F Shen, Y Fan, H Su, Y Zhu, Y Chen, W Liu, WL Young and GY Yang. Adeno-associated viral vector-mediated hypoxia-regulated VEGF gene transfer promotes angiogenesis following focal cerebral ischemia in mice. Gene Therapy, 15: 30-39, 2008

  • *H Su, Y Yeghiazarians, A Lee, Y Huang, J Arakawa-Hoyt, J Ye, G Orcino, W Grossman and Y W Kan. AAV Serotype 1 Mediates more Efficient Gene Transfer to Pig Myocardium than AAV Serotype 2 and Plasmid. J Gene Med. Nov. 29, 2007. (*corresponding author)

  • H Su and YW Kan. Adeno-associated viral vector-delivered hypoxia-inducible gene expression in ischemic hearts. Methods Mol Biol. 366:331-42, 2007

  • Q Hao, Y Chen, Y Zhu, Y Fan D Palmer, H Su, WL Young, and GY Yang. Neutrophil Depletion Decreases VEGF-Induced Focal Angiogenesis in the Mature Mouse Brain. Journal of Cerebral Blood Flow & Metabolism, 27:1853-1860, 2007.

  • F Shen, H Su, Y Fan, Q Zhu, W Liu, WL Young, and GY Yang. Adeno-Associated Viral Vector-Mediated Hypoxia-Response Element-Regulated Vascular Endothelial Growth Factor Gene Expression Attenuates Ischemic Brain Injury Following Focal Cerebral Ischemia in Mice. Stroke, 37: 2601-2606, 2006.

  • *H Su, Y Huang, J Takagawa, A Barcena, J Arakawa-Hoyt, J Ye, W Grossman and YW Kan. AAV Serotype-1 Mediates Early Onset of Gene Expression in Mouse Hearts and Results in better Therapeutic Effect. Gene Therapy, 13(21): 1495-502, 2006. (*corresponding author)

  • F Shen, H Su, Y Fan, Y Zhu, Y Chen, YW Kan, WL Young, and GY Yang. Recombinant Adeno-Associated Viral Vector Encoding Human VEGF165 Induces Neomicrovessel Formation in the Adult Mouse Brain. Frontiers Bioscience, Sep 1;11:3190-8, 2006.

  • *H Su, S Joho, Y Huang, A Barcena, J Arakawa-Hoyt, W Grossman and YW Kan. Adeno-Associated Viral Vector Delivers Cardiac-Specific and Hypoxia-Inducible VEGF Expression in Ischemic Mouse Hearts. Proc Natl Acad Sci USA, 101:16280-16285, 2004. (*corresponding author).

  • DS Chang, H Su, GL Tang, LS Brevetti, R Sarkar, R Wang, YW Kan and LM Messina. Adeno-Associated Viral Vector Mediated Gene Transfer of Vascular Endothelial Growth Factor Normalizes Skeletal Muscle Oxygen Tension and Induces Arteriogenesis in Ischemic Rat Hindlimb. Molecular Therapy, 7:44-51, 2003

  • H Su, J Arakawa-Hoyt and YW Kan. Adeno-Associated Viral Vector Mediated Hypoxia Response Element Regulated Gene Expression in Mouse Ischemic Heart Model. Proc Natl Acad Sci USA, 99:9480-9485, 2002.

  • H Ruan, H Su, L Hu, KR Lamborn, YW Kan and DF Deen. A Hypoxia-Regulated Adeno-Associated Virus Vector for Cancer-Specific Gene Therapy. Neoplasia, 3(3): 1-9, 2001.

  • H Su, R. Lu and Y. W. Kan: Adeno-Associated Viral Vector (AAV) Mediated Vascular Endothelial Growth Factor (VEGF) Gene Transfer Induces Formation in Ischemic Heart. Proc Natl Acad Sci USA, 97: 13801-13806, 2000.

  • H Su, R Lu, R Ding and YW Kan. Adeno-Associated Viral-Mediated Gene Transfer to Hepatoma: Thymidine Kinase/Interleukin 2 is more Effective in Tumor Killing in Non-Ganciclovir (GCV)-Treated Than in GCV-Treated Animals. Molecular Therapy, 1(6): 509-515, 2000.

  • H Su, R Lu, JC Chang and YW Kan. Tissue-Specific Expression of Herpes Simplex Virus Thymidine Kinase Gene Delivered by Adeno-Associated Virus Inhibits the Growth of Human Hepatocellular Carcinoma in Athymic Mice. Proc. Natl. Acad. Sci. USA, 94: 13981-13896, 1997.

  • JD Liou, YY Ma, LH Gibson, H Su, N Charest, YF Lau and TL Yang-Feng. Cytogenetic and Molecular Studies of a Familial Paracentric inversion of Y Chromosome Present in a Patient with Ambiguous Genitalia. American Journal of Medical Genetics, 70(2):134-7, 1997.

  • YW Kan, N Kasahara, A Dozy, C Wong, X Han and H Su. Tissue-Specific Gene Delivery and Gene Expression. J Clin Biochem Nutr, 21:80-81, 1996

  • H Su, JC Chang, SM Xu, and YW Kan. Selective Killing of AFP-Positive Hepatocellular Carcinoma Cells by Adeno-Associated Virus Transfer of the Herpes Simplex Virus Thymidine Kinase Gene. Human Gene Therapy, 7: 463-470, (1996)

  • H Su and Y-FC Lau. Identification of the Transcriptional Unit, Structural Organization and Promoter Sequence of the Human Sex Determining Region Y (SRY) Gene Using a Reverse Genetic Approach. Am. J Hum. Genet., 52:24-38, 1993.

 

 


Contact the CCR
Copyright © 2008 University of California Regents.
All Rights Reserved.
Page best viewd above 1280x1024 using Mozila Firefox

All research involving human subjects or specimens adhere to the guidelines set forth by the Institutional Review Board of the University of California San Francisco.